Ascendis Pharma A/S Postemployment Benefit Expense Defined Benefit Plans
Ascendis Pharma A/S (ASND) reported Postemployment Benefit Expense Defined Benefit Plans of EUR 6.92 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2026-02-11
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|
| 2025-12-31 | 6.92M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 4.49M EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | 4.40M EUR 20-F · filed 2026-02-11 |
| 2022-12-31 | 4.16M EUR 20-F · filed 2025-02-12 |
| 2021-12-31 | 2.42M EUR 20-F · filed 2024-02-07 |
| 2020-12-31 | 943.00K EUR 20-F · filed 2023-02-16 |
| 2019-12-31 | 648.00K EUR 20-F · filed 2022-03-02 |
| 2018-12-31 | 444.00K EUR 20-F · filed 2021-03-10 |
| 2017-12-31 | 324.00K EUR 20-F · filed 2020-04-03 |
| 2016-12-31 | 49.00K EUR 20-F · filed 2019-04-03 |
| 2015-12-31 | 42.00K EUR 20-F · filed 2018-03-28 |